eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2011
vol. 28
 
Share:
Share:

Original paper
Immunoreactivity of transglutaminase cross-linked milk proteins in fermented milk product obtained with Lactobacillus acidophilus

Barbara Wróblewska
,
Anna Kaliszewska
,
Elżbieta Malinowska
,
Agnieszka Troszyńska

Post Dermatol Alergol 2011; XXVIII, 4: 261–267
Online publish date: 2011/08/31
Article file
- Immunoreactivity.pdf  [0.24 MB]
Get citation
 
 

Introduction

Food hyper-reactivity, also called a food allergy, is becoming a widespread disease. It is estimated that in well-developed countries over 6% of children and 3-4% of adults suffer from this ailment [1-3]. The allergy to milk proteins is the most common one within newborns and children up to two years old. Milk is a highly valuable food product in human nutrition and, thus, it is justified to search for technologies that would lower antigenicity and allergenicity of particular milk proteins so that they could also be consumed by people with a diagnosed milk allergy.

Presence or absence of some bacteria species in the digestive tract is one of the factors that influence the emergence of a food allergy. It has been observed that the intestine is colonised faster by favourable bacteria species, enterobacterium, enterococci, eubacteria, as well as the bacteria of the Lactobacillus genus in groups of children from developing countries (e.g. Estonia) [4]. Food-allergic newborns in developed countries (e.g. Finland) were characterised by a higher number of clostridia while that of bifidobacteria was lower [5]. The efficient work of the digestive tract and the connected immune system (gut-associated lymphoid tissue – GALT) may be modulated by stimulation with the addition of microflora of a probiotic nature.

Lactobacillus acidophilus is one of the better known and described species. Some strains of L. acidophilus play a role in limiting the amount of intestinal infections resulting from both rotavirus and bacteria-based diarrhoeas; they also enhance digestion and lactose absorption. Their actions also include production of substances inhibiting the development of some types of neoplasms, stimulation of the immune response to undesired intestinal microorganism, and control of cholesterol in the serum. While competing with pathogens for receptors, they block the growth of pathogenic organisms and prevent their reproduction and colonisation of the intestine. It is this bacterium that produces natural antibiotics – acidophilin, lactacin, and lactocidin – that in vitro manifest very strong antagonistic actions towards such bacteria as Escherichia coli, Klebsiella, Salmonella, Shigella, Staphylococcus, and Vibrio [6]. Also, L. acidophilus has some antiproliferative properties that inhibit creation of a large populations of Th2 lymphocytes that are crucial in developing food allergies; it also significantly increases the secretion of the IL-12 cytokine, and, to a lesser degree, of the IL-10 one, tumour necrosis factor (TNF), and interferon (IFN)-g. The latter two pro-inflammatory cytokines participate actively in sealing up the intracellular connections and are crucial for Th0 to Th1 cell differentiation [7]. Moreover, L. acidophilus decreases the secretion of IL-4 that stimulates the synthesis of E-class antibodies.

The L. acidophilus strain also has an influence on occurrences of non-specific immune reactions. It has been proved that consumption of fermented milk with L. acidophilus for three weeks entailed a decreased phagocytic activity of leukocytes in human peripheral blood. Granulocytes demonstrated a higher capacity of phagocytosis that monocytes. That increase was maintained for 6 weeks after the consumption of fermented milk was stopped. It is speculated that it is a result of modulation of surface molecules that participate in capture of bacteria by leukocytes, as well as a result of the creation of increased amounts of free oxygen radicals and lysosomal enzymes capable of fast destruction of microorganisms [8].

Addition of appropriate microflora is not the only factor that facilitates production of a low-antigen milk drink. It has been observed that addition of microbiological transglutaminase (m-TG) enables trans-protein and trans-peptide connections, which eliminates the places of allergenic epitopes [9]. In spite of its cross-linking properties, m-TG does not connect to human immunoglobulin E, and its daily human-safe dose may be 8-13 mg/day depending on its consumer’s age. It has been shown that the hydrolysis of m-TG by pepsin in stomach conditions (pH 2) caused formation of peptides within one minute; yet, trypsin did not hydrolyse m-TG even after 48 h of the reaction. At the same time, when applying the research protocol that makes the guidelines of the FAO/WHO Decision Tree, no danger has been stated in terms of allergenic potential of m-TG [10].

Aim

The aim of this study was to propose a technology for production of a fermented milk drink using the L. acidophilus strain and a simultaneous addition of m-TG, which causes a reduction of the milk protein immunoreactivity (b-lactoglobulin, -lactalbumin and casein fractions) and an improvement of the sensory qualities of the modified drink.

Material and methods

Research material

The examined samples consisted of a fermented drink produced using the microbiological L. acidophilus strain and simultaneous addition of m-TG.

Defining the amount of the antigen with the competitive ELISA

Microplates were coated with a solution of antigens (-casein C-6780, b-casein C-6905, k-casein C-0406, -lactalbumin L-6010, b-lactoglobulin L-6879 by Sigma). The samples of properly diluted fermented drinks in the amount of 50 µl were incubated together with 50 µl of a rabbit serum solution containing specific IgG antibodies obtained and validated during our previous research. Then, 100 µl of goat’s anti-rabbit immunoglobulin G conjugate marked with horseradish peroxidase (Sigma A-6154) were added. In the next phase a substrate was added: a 100% solution of 3,3’,5,5’-tetramethylbenzidine (TMB Sigma 5525). After 30 min of incubation, the reaction was stopped with 2 M sulphuric acid (VI) solution and the absorbance was read at the wavelength of 450 nm with the SUNRISE reader by TECAN. The applied Competitive ELISA is a method developed in our department to validate food product groups.

Percentages of immunoreactivity changes for the proteins in the examined samples were calculated as the amount of the antigen observed at the 50% share of antibody bonds directed towards the standard protein.

Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting

The electrophoresis was performed in denaturing conditions according to Laemmili’s method using a 12% polyacrylamide gel [11]. The process was carried out at the direct current of 120 V. For immunoblotting, the separated proteins were transferred onto a nitrocellulose membrane at the current of 30 V for 20 h. Then, the membrane was incubated at 4°C for 10 h with human serum collected from patients with a food allergy to cow’s milk proteins. After washing the membrane with phosphate buffer, it was incubated for 2 h with goat’s anti-human E-class antibody (Sigma A-9667). The membrane was stained with a solution of 2-chloro-2-naphthol (Sigma, C-6788) with the addition of methanol and H2O2 and the reaction was stopped by washing the membrane in distilled water.

Sensory evaluation of products with and without transglutaminase addition

The sensory assessments of the fermented products were carried out by a panel consisting of 9 members selected and trained according to ISO guidelines [12]. All assessors have passed the basic taste test, the odour test and the colour vision test.

In the sensory evaluation, each panelist was asked to assess the samples for overall quality based on the overall colour, odour, taste and texture [13]. An unstructured graphical scale was 10 cm long and anchored on both ends: disliked (0) – extremely liked (10). Treatment means were compared using Fisher’s protected least significant difference test (LSD, at p  0,05).The assessments were carried out at a sensory laboratory room, which fulfils the requirements of the ISO standards [14]. The results were collected and calculated using software package FIZZ, Biosystemes, v. 2.45 A, France.

Results

Using the L. acidophilus strain to obtain a fermented milk product decreased the immunoreactive potential of particular milk proteins that belong to a group of major allergens. The addition of m-TG caused a further decrease of that property, particularly in relation to several proteins (-casein, k-casein, and b-lactoglobulin) (Table 1).

In the presented study, the products were analysed after 30 days of cooling storage that corresponded with the expiry date of the dairy products. It was observed that a further decrease of immunoreactivity occurred in all the proteins. The results obtained for b-lactoglobulin showed an immunoreactivity reduction of over 86%. The casein fractions turned out to be the most resistant ones and their immunoreactivity was about a dozen per cent. The whey proteins (-lactalbumin and b-lactoglobulin) as well as k-casein were detected in trace amounts (0.03-1.82%) (Table 1).

The immunoblot enabled tracing of the reaction between the antibodies in the sera of patients with the food allergy and the milk proteins. It was found that all the samples of the milk drinks produced using L. acidophilus were characterised by occurrences of a reaction between the patients’ specific E-class antibodies and the milk proteins with molecular weight of 66-80 kDa, which may respond to the presence of bovine blood serum albumin (BSA = 66 kDa) and lactoferrin (LF = 80 kDa). Additionally, the presence of a strongly reactive fraction of -casein in the fresh and stored drinks was found, regardless of the m-TG enzyme addition (Fig. 1).

The sensory evaluation of the fermented drinks was carried out directly after the completed production process and after 30 days of cool storage (Fig. 2). The m-TG-free product was characterised by some intensively palpable negative features, which included the smell and the bitter taste of ‘burned milk’. Its aftertaste and coating of the mouth cavity were also strongly felt. The product, however, was also characterised by a high level of positive features such as its sour taste and the smell of kefir.

The addition of m-TG increased the palpability of the taste and the smell of soured milk, which is desired in milk products of that type. Also, an improvement of visual properties of the drink occurred – its density and surface smoothness were increased and the taste and the smell of ‘burned milk’ were totally neutralised.

After 30 days of storing the drink that contained the addition of m-TG its properties of the sour taste and smell as well as the smell of soured milk were reduced. Also, the aftertaste and coating of the mouth cavity were less intensive. The obtained drink had the properties of a mild fermented product, which is favoured by its potential consumers. In both the analysed products, their remaining values for the organoleptic evaluation did not change significantly during the storage time.

The results showed that both the addition of the m-TG enzyme and storage had effects on the sensory quality of fermented products (Fig. 2). The samples with m-TG obtained higher scores for overall quality them the products without m-TG. The former obtained 4.4 and 4.7 points in the 10-unit conventional scale while the latter 2.0 and 2.9 points, respectively. It indicated that m-TG might contribute to improve the sensory properties of fermented products.

It was noted that addition of m-TG during the drink production increased the general quality of the product and nearly a twofold increase of the general sensory quality was noted after adding m-TG to the fresh drink. The storage time also contributed to the further increase of the general desirability of the products (Fig. 2).

Discussion

The basis of newborns’ diet is usually their mothers’ milk. There are, however, cases when due to various reasons a decision is made to include milk of different species, most often cow’s milk and its products, into their nutrition faster that usual. Cow’s milk contains on average 3-4% proteins in total, nearly 2.5% of which is made up of casein and the rest of whey proteins. Over 100 characterised proteins and peptides isolated from milk have allergenic properties. The most common are casein fractions (s1, s2, b, k, g), which are commonly referred to as allergen Bos d 8, as well as whey proteins -lactalbumin (-la, Bos d 4) and b-lactoglobulin (b-lg, Bos d 5). The IgE-dependent epitopes are presented in Table 2. A change to the peptide structures may be conducted by denaturation, hydrolysis, chemical modifications, and microbiological-culture-aided transformations.

Lactic acid fermentation bacteria may activate the immune system cells of the digestive tract as a result of direct contact with the whole bacterium cell, its fragment or metabolites, as a result of modifications to the intestinal flora and allergen permeability through the intestinal walls, or as a result of introduced adjuvants that influence the course of the immune response [15].

The L. acidophilus strain was used in the study as it naturally inhabits the digestive and genital tracts. It is also present in food products. As a result of the activities of microbiological strains of Lactobacillus sp., the milk proteins were hydrolysed under the influence of the secreted proteolytic enzymes. Due to that process, the antibodies previously identified by the epitopes, mostly conformational ones, might have been destroyed. Occurrence of new amino acid sequences with allergenic properties, which had previously been bound in the protein structure, were also possible.

The addition of m-TG, an enzyme with cross-linking properties, was also used in the production of the milk drink, which made it possible to aggregate the obtained proteins and peptides, probably also in the places of the allergenic epitopes, thus decreasing the immunoreactivity. At the same time, the actions of m-TG caused building of the revealed antigen determinants into the newly-created protein agglomerates in a way that blocked their identification by the antibodies directed towards the main milk allergens.

It was observed that the addition of m-TG caused a significant decrease in the immunoreactivity of the two main milk allergens, -casein (by 50%) and b-lactoglobulin (by over 80%), in relation to the fresh probiotic drink produced without m-TG. The time of cool storage had a negative influence on bonding of the antigen determinants characteristic for the presence of -lactalbumin and k-casein, causing an increase in the level of immunoreactivity by 65% and over 200% respectively in relation to the fresh drink (Table 1). It should be stressed, however, that those are not the immunodominant milk allergens. Yet, the allergenic potential of the remaining proteins kept decreasing. Data concerning characterized IgE-mediated epitopes are shown in Table 2.

The immunoblot analysis has provided some valuable information on the reaction between IgE from the sera of the people allergic to milk with the proteins in the ready-to-consume milk drink. Proving an explicit reaction between the antibodies and the milk proteins with higher molecular masses turned out to be crucial. Most likely, those included BSA (66 kDa), lactoferrin (70-80 kDa), and also -casein (27-30 kDa) (Figure 1); however, some further research on the identification of reactive milk proteins is required. Those high-molecular proteins are much more resistant to high temperature, enzymes, and the influence of chemical compounds than the proteins of lower molecular masses, and therefore they remained in the environment of the milk product and their epitopes reacted with the patients’ antibodies. However, no reaction of the E-class antibodies with the whey proteins (e.g. b-lactoglobulin) was observed though those proteins are often presented in the available literature as the basic allergens within milk proteins [16]. b-Lactoglobulin is destroyed during heating in the so-called low-temperature pasteurisation, from 74°C to 90°C [17]. Circular dichroism analysis has made it possible to identify that circa 50% of the changes in a b-lactoglobulin molecule occur during the first 15 s of heating the protein at the temperatures of 80-95°C [18]. Presently, high-temperature pasteurisation methods are used together with pasteurisation, which aims at obtaining fully sterile milk where labile proteins and their epitopes are denaturised easily. However, some chemical structures resistant to technological processing remain, and at the same time, as a result of drastic production conditions, some new non-specific bonds are created (protein-sugar, protein-fat) that are difficult for the immune system to identify.

Proposing a mixed technology (hydrolytic and cross-linking) for the production of fermented milk drinks with m-TG seems to be reasonable for obtaining a low-antigen drink. The m-TG-modified food produced so far is perceived as non-allergic. No cases of IgE-dependent allergy due to the presence of m-TG in food have been recorded. Is has been demonstrated that the human body is capable of total hydrolysis of isopeptide cross-linked protein bonds in the digestive tract, which conditions the availability and digestibility of lysine. The enzymes responsible for cleavage of chemical bonds formed during cross-linking include g-glutamine-cyclotransferase localised in the kidneys, and g-glutamine-transpeptidase localised also in the kidneys and the intestinal brush border [19].

Conclusions

As a result of the performed research, it was found that the fermented milk drink produced using the selected L. acidophilus strain is a product with reduced immunoreactivity of all the main milk allergens. Adding the cross-linking enzyme m-TG during the technological process caused a further decrease in the antigen potential of the ready-to-consume drink, particularly that of - and k-casein a, as well as b-lactoglobulin. During the product storage, within 30 days guaranteed before its expiry date, a further reduction of immunoreactivity occurred. The immunoblot analysis proved that the proteins of the highest allergic potential consisted of the proteins resistant to high temperatures and proteolytic enzymes, i.e. the proteins with the highest molecular masses. Those most likely include BSA and LF but some further studies on their detailed identification are required. However, no reaction has been observed between E-class antibodies in the patients’ sera and the proteins commonly recognised as the strongest allergens: b-lactoglobulin and -casein.

Moreover, the obtained drinks are characterised by favourable sensory properties that have been enhanced as a result of the m-TG addition, which makes the products attractive for a potential customer.

Summing up, the simultaneous application of the L. acidophilus strain and m-TG may be used to produce a low-antigen milk product supplementing the diet of people with food allergies to milk proteins.

Acknowledgments

The study was performed within the research financed as grant No. N31204231/2678. The authors would like to thank Piotr Kołakowski PhD, DSc and Katarzyna Pawlikowska MSc from Danisco Biolacta Sp.z o.o. in Olsztyn for preparing and sharing samples of fermented products, as well as Agnieszka Krauze MD, PhD from the Medical University of Warsaw for her cooperation in selecting patients’ sera for the research.

References

 1. Schirer SH, Samson HA. Ford allergy: recent advances in pathophysiology and treatment. Ann Rev Med 2009; 60: 261-77.

 2. Kaczmarski M, Korotkiewicz-Kaczmarska E, Bobrus-Chociej A. Aspekty epidemiologiczne, kliniczne i społeczne alergii pokarmowej. Część I. aspekty epidemiologiczne. Przegl Pediatr 2008; 38: 215-7.

 3. Sampson HA. Food allergy. J Allergy Clin Immunol 2003; 111: 540-7.

 4. Sandin A, Annus T, Björkstén B, et al. Prevalence of self-reported food allergy and IgE antibodies to food allergens in Swedish and Estonian schoolchildren. Eur J Clin Nutr 2005; 59: 399-403.

 5. Matricardi PM, Bjorksten B, Bonini SJ, et al. Microbial products in allergy prevention and therapy. Allergy 2003; 58: 461-71.

 6. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. Immunol Medical Microbiol 2002; 34: 245-53.

 7. Resta-Lenert S, Barett KE. Probiotics and commensals reverse TNF-αlpha and IFN-gamma induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006; 130: 731-46.

 8. Gill HS. Stimulation of the immune system by lactic cultures. Int Dairy J 1998; 8: 535-44.

 9. Wróblewska B, Kołakowski P, Pawlikowska K, et al. Influence of the addition of transglutaminase on the immunoreactivity of milk proteins and sensory quality of kefir. Food Hydrocolloids 2009; 23: 2434-45.

10. Padersen MH, Hansen TK, Sten E. Evaluation of the potential allergenicity of the enzyme microbial transglutaminase using the 2001 FAO/WHO Decision Tree. Mol Nutr Food Res 2004; 48: 434-40.

11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage TL. Nature 1970; 227: 680-5.

12. ISO 8586.1-1993. Sensory analysis – General guidance for the selection, training and monitoring of assessors – Part 1: selected assessors.

13. Lawless HT, Heymann H. Sensory evaluation of food: principles and practices. Chapman and Hall, New York 1999; 341-72.

14. ISO 8589:1998. Sensory analysis – General guidance for the design of test rooms.

15. Kirjavainen PV, Apostolo E, Salminen, et al. Nowe aspekty stosowania probiotyków w leczeniu alergii pokarmowej. Alergia Astma Immunol 2001; 6: 1-6.

16. Savilahti E, Saarinen KM, Savilahti E. Specific antibodies to cow’s milk proteins in infants: effect of early feeding and diagnosis of cow’ milk allergy. Eur J Nutr 2010; 49: 501-4.

17. Ehn BM, Ekstrand B, Bengtsson U, et al. Modification of IgE binding during heat processing of the cow's milk allergen beta-lactoglobulin. J Agric Food Chem 2004; 52: 1398-403.

18. Chen WL, Hwang MT, Liau CY, et al. Beta-lactoglobulin is a thermal marker in processed milk as studied by electrophoresis and circular dichroic spectra. J Dairy Sci 2005; 88: 1618-30.

19. Jaros D, Partschefeld C, Henle T, Rohm H. Transglutaminase in dairy products: chemistry, physics, applications. J Text Studies 2008; 37: 113-55.

20. Spuergin P, Mueller H, Walter M, et al. Allergenic epitopes of bovine alpha S1-casein recognized by human IgE and IgG. Allergy 1996; 51: 306-12.

21. Chatchatee P, Jarvinen KM, Bardina L, et al. Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow's milk allergy. J Allergy Clin Immunol 2001; 107: 379-83.

22. Elsayed S, Hill DJ, Do TV. Evaluation of the allergenicity and antigenicity of bovine-milk alphas1-casein using extensively purified synthetic peptides. Scand J Immunol 2004; 60: 486-93.

23. Nakajima-Adachi H, Hachimura S, Ise W, et al. Determinant analysis of IgE and IgG4 antibodies and T cells specific for bovine alpha(s)1-casein from the same patients allergic to cow's milk: existence of alpha(s)1-casein-specific B cells and T cells characteristic in cow's-milk allergy. J Allergy Clin Immunol 1998; 101: 660-71.

24. Cerecedo I, Zamora J, Shreffler WG, et al. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol 2008; 122: 589-94.

25. Busse PJ, Järvinen KM, Vila L, et al. Identification of sequential IgE-binding epitopes on bovine alpha(s2)-casein in cow's milk allergic patients. Int Arch Allergy Immunol 2002; 129: 93-6.

26. Järvinen KM, Beyer K, Vila L, et al. B-cell epitopes as a screening instrument for persistent cow's milk allergy. J Allergy Clin Immunol 2002; 110: 293-7.

27. Adams SL, Barnett D, Walsh BJ, et al. Human IgE-binding synthetic peptides of bovine beta-lactoglobulin and alpha-lactalbumin. In vitro cross-reactivity of the allergens. Immunol Cell Biol 1991; 69: 191-7.

28. Ball G, Shelton MJ, Walsh BJ, et al. A major continuous allergenic epitope of bovine beta-lactoglobulin recognized by human IgE binding. Clin Exp Allergy 1994; 24: 758-64.

29. Beretta B, Conti A, Fiocchi A, et al. Antigenic determinants of bovine serum albumin. Int Arch Allergy Immunol 2001; 126: 188-95.
Copyright: © 2011 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.